(Q43745081)

26 November 2017

title

MS-377, a novel selective sigma(1) receptor ligand, reverses phencyclidine-induced release of dopamine and serotonin in rat brain (English)

1 reference

26 November 2017

0 references

Takahashi S

1

1 reference

26 November 2017

Horikomi K

series ordinal

2

1 reference

26 November 2017

Kato T

series ordinal

3

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

European Journal of Pharmacology

26 November 2017

published in

1 reference

26 November 2017

volume

427

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

211-219

1 reference

Phencyclidine and dizocilpine modulate dopamine release from rat nucleus accumbens via sigma receptors

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

The role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the modulation of 5-HT release--III. Clozapine and the novel putative antipsychotic S 16924.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Ceruletide inhibits phencyclidine-induced dopamine and serotonin release in rat prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Clozapine decreases serotonin extracellular levels in the nucleus accumbens by a dopamine receptor-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

The effects of phencyclidine on the uptake of 3H-catecholamines by rat striatal and hypothalamic synaptosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Effects of sigma receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Biphasic effect of sigma receptor ligands on the extracellular concentration of dopamine in the striatum of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Neuroendocrinological and neurochemical effects of sigma ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Phencyclidine and sigma opiate receptors in brain: biochemical and autoradiographical differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Binding properties of [3H]MS-377, a novel sigma receptor ligand, to rat brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

In vivo functional interaction between phencyclidine binding sites and sigma receptors to produce head-weaving behavior in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Sigma 1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Effects of the serotonin2A/2C receptor agonist and antagonist on phencyclidine-induced dopamine release in rat medial prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Acute effects of sigma ligands on the extracellular DOPAC level in rat frontal cortex and striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2Asites for PCP-induced locomotion in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

NE-100, a novel sigma receptor ligand: in vivo tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Effects of phencyclidine on [3H]catecholamine and [3H]serotonin uptake in synaptosomal preparations from rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Guinea pig vas deferens contains sigma but not phencyclidine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Involvement of sigma 1 receptors in methamphetamine-induced behavioral sensitization in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Effects of a novel, selective, sigma1-ligand, MS-377, on phencyclidine-induced behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Implications of normal brain development for the pathogenesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Effects of sigma(1) receptor ligand, MS-377 on apomorphine- or phencyclidine-induced disruption of prepulse inhibition of acoustic startle in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

NE-100, a novel sigma ligand: effects on [3H]TCP binding to intact primary cultured neuronal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Potentiation of phencyclidine-induced dopamine release in the rat striatum by the blockade of dopamine D2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901254-7

10.1016/S0014-2999(01)01254-7

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference